Mexico Sepsis Diagnostics Market Size & Outlook, 2022-2030
Mexico sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
Mexico sepsis diagnostics market highlights
- The Mexico sepsis diagnostics market generated a revenue of USD 11.1 million in 2022 and is expected to reach USD 21.3 million by 2030.
- The Mexico market is expected to grow at a CAGR of 8.4% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 11.1 million |
| Market revenue in 2030 | USD 21.3 million |
| Growth rate | 8.4% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.1% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 21.3 million by 2030.
Blood culture media was the largest segment with a revenue share of 38.74% in 2022. Horizon Databook has segmented the Mexico sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The rising incidence of sepsis, especially among vulnerable populations such as the elderly and those with chronic conditions, is driving the market in Mexico. A report in NCBI stated that the incidence of HAIs is growing in the country, which is a leading cause of sepsis.
The growing number of infections in this region is expected to act as a driver for the sepsis diagnostics market. Organizations in Mexico, such as Sepsis Foundation Mexico, are working toward raising awareness and helping in the detection and rehabilitation of patients across the nation.
The 2022 Bulletin of Infections Associated with Health Care by the Hospital Epidemiological Surveillance Network (RHOVE) reported Staphylococcus aureus as the fifth most common microorganism responsible for HAIs in Mexico, accounting for 2,091 cases.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico sepsis diagnostics market size, by product, 2018-2030 (US$M)
Mexico Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
